Mankind Pharma Reschedules Q2 & H1 FY27 Earnings Call to 26th Oct'26
Mankind Pharma Ltd 路 Intimation 路 23 Oct 2026, 12:21 am
Mankind Pharma Reschedules Q2 & H1 FY27 Earnings Call to 26th Oct'26 Mankind Pharma Limited has advanced its Q2 & H1 FY27 earnings conference call originally scheduled for 26th Oct'26 at 06:00 PM IST to 05:00 PM IST on the same date. The company re-submitted the intimation to provide an updated, accessible meeting link after encountering technical issues with the link in its previous filing. All other terms and details regarding the earnings call remain unchanged.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Please find attached intimation regarding ESG Rating 路 05 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
